The International Myeloma Foundation kicked off the 2018 March Myeloma Action month with the focus on the #MyelomaWarrior. On the plane I was on from DFW to SAN to attend the 60th American Society of Hematology Annual Meeting & Exposition held in San Diego from December 1 – 4, 2018, there was a Warrior, in […]
Yelak Biru
Diagnosed at the young age of 25 with stage III multiple myeloma, Yelak Biru is a patient turned myeloma research advocate. Working with a team of medical practitioners and educating himself through support group leadership, information resources, advocacy sites, social media, and the IMF, Yelak has successfully integrated myeloma to his life for over two decades.
Follow Yelak on Twitter
With Myeloma, Even a 20-year Survivor Always Has More to Learn
Anytime you can reduce dexamethasone (dex), do it There was one specific trial that was presented at this year’s ASH that studied the benefit of dex. The study was conducted with 199 intermediate fit patients with Revlimid and dexamethasone (Rd) induction (9 cycles) and Revlimid (R) maintenance until progression compared to Rd induction and Rd […]
Looking Back to the Future
During the summer of 2018, I spent some time in Europe facilitating the Global Myeloma Action Network meeting, attending IMWG conference and sparring, from a patient perspective, with Dr. S. Vincent Rajkumar on the topic of “Do I Need a Stem Cell Transplant for the Treatment of Myeloma?” and sharing the stage with leading researchers […]